BEIJING, May 17, 2012 /PRNewswire-Asia-FirstCall/ --
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or
the "Company"), an emerging leader in the development, assembly,
marketing and sale of medical devices and homecare medical
products, today announced that the Company will present at the CFA
2012 Cross-Continental Summit on Investment, to be held at the
Shanghai Purple Mountain Hotel in Shanghai on May 18,
2012.
(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO
)
Dehaier's Chairman and CEO, Mr. Ping Chen, will present and
participate in the "Health Care and Medical" panel discussion at
4:40 p.m. local time on Friday, May 18, 2012 and meet with investors
throughout the day. Additional information on CFA and the
conference (including Mr. Chen's full biography) can be found by
visiting the association's website at
http://www.cfasociety.org/china/ and clicking the appropriate
links.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy),
Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent
Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents and five software
copyrights; additionally Dehaier has two pending software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular statements about Dehaier's attendance at the referenced
summit. These statements are subject to uncertainties and risks
including, but not limited to, product and service demand and
acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, future
developments in payment for and demand for medical equipment and
services, implementation of and performance under the joint venture
agreement by all parties, and other risks contained in reports
filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after
the date hereof.
Contact Us
Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
The Equity Group Inc.
Katherine Yao
+86 10-6587-6435
kyao@equityny.com
In America
The Equity Group Inc.
Adam Prior
(212) 836-9606
aprior@equityny.com
SOURCE Dehaier Medical Systems Ltd.